arrow
A

Andries M. Bergman

the netherlands cancer institute
H指数:44
被引数:9,409

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

全基因组CRISPR筛选在人前列腺癌细胞中揭示了巨噬细胞介导的细胞杀伤的驱动因子,并将AR定位为肿瘤内源性免疫调节因子

2026-07-280
PRE
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer

去势抵抗性前列腺癌中AR位点突变的谱系和临床分级

2025-10-270
OAAI
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis

卡巴他赛与阿比特龙或恩扎卢胺治疗既往多西他赛治疗后的不良预后转移性去势抵抗性前列腺癌:一项含循环肿瘤DNA分析的II期试验

2025-09-300
OAAI
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair–deficient Metastatic Castration-resistant Prostate Cancer

PD-(L)1免疫疗法在DNA错配修复缺陷型转移性去势抵抗性前列腺癌患者中的疗效

2025-07-120
OAAI
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer

表观遗传谱分析鉴定了内分泌抵抗的标志物及转移性去势抵抗性前列腺癌的治疗选择

2025-07-020
OAAI
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer

KEYNOTE-921研究中患者报告结局:帕博利珠单抗联合多西他赛和泼尼松治疗转移性去势抵抗性前列腺癌

2025-05-130
PRE
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration- resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

先前接受卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的177前列腺特异性膜抗原活性和预后决定因素: PACAP研究

2024-10-010
OA
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
2024-08-130
OAAI
Whole genome and transcriptome analysis of paired metastatic biopsies identified resistance mechanisms in castration-resistant prostate cancer
2023-06-020
PRE
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

前列腺癌的遗传方面和分子检测: 来自荷兰多学科共识会议的报告

2023-03-015
OAAI